HALEON PLC
LSE:HLN

Watchlist Manager
HALEON PLC Logo
HALEON PLC
LSE:HLN
Watchlist
Price: 380.3 GBX 2.12% Market Closed
Market Cap: 34.4B GBX
Have any thoughts about
HALEON PLC?
Write Note

Net Margin
HALEON PLC

10.8%
Current
10%
Average
3.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.8%
=
Net Income
1.2B
/
Revenue
11.2B

Net Margin Across Competitors

Country UK
Market Cap 34.7B GBP
Net Margin
11%
Country FR
Market Cap 176B EUR
Net Margin
15%
Country UK
Market Cap 117.3B GBP
Net Margin
11%
Country IN
Market Cap 5.7T INR
Net Margin
17%
Country DE
Market Cap 27.7B EUR
Net Margin
8%
Country US
Market Cap 25.1B USD
Net Margin
1%
Country JP
Market Cap 2.9T JPY
Net Margin
5%
Country IN
Market Cap 1.2T INR
Net Margin
-3%
Country IN
Market Cap 909.1B INR
Net Margin
14%
Country US
Market Cap 10.2B USD
Net Margin
12%
Country IN
Market Cap 741.3B INR
Net Margin
24%
No Stocks Found

HALEON PLC
Glance View

Market Cap
34.7B GBX
Industry
Consumer products

Haleon PLC emerged as a significant player in the global consumer health market when it was spun off from GlaxoSmithKline in July 2022. As a standalone entity, Haleon focuses on delivering everyday health products that enhance personal well-being, relying on a portfolio brimming with trusted brands like Sensodyne, Panadol, and Voltaren. With an impressive presence in over 100 countries, the company capitalizes on the growing consumer shift towards preventative healthcare and wellness, offering a range of over-the-counter medications, oral health products, and vitamins. This strategic approach positions Haleon not only as a trusted name but also as a vital contributor to the ongoing trend of self-care, making it an intriguing option for long-term investors seeking growth in resilient sectors. As Haleon charts its path forward, the company emphasizes sustainable growth and innovation, seeking to resonate with health-conscious consumers amid an increasingly competitive landscape. By investing in research and development, Haleon aims to expand its product offerings and enhance its market position. The company's focus on operational efficiency, coupled with strategic partnerships and an agile supply chain, reflects its commitment to driving profitability and shareholder value. With a strong foundation rooted in consumer trust and a forward-looking vision, Haleon PLC stands ready to navigate the evolving health landscape, presenting an appealing narrative for investors drawn to enterprises poised for sustainable success.

HLN Intrinsic Value
336.95 GBX
Overvaluation 11%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.8%
=
Net Income
1.2B
/
Revenue
11.2B
What is the Net Margin of HALEON PLC?

Based on HALEON PLC's most recent financial statements, the company has Net Margin of 10.8%.